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Chloroethyl nitrosoureas constitute an important family of cancer chemotherapeutic agents, used in the treatment of vari-
ous types of cancer. They exert antitumor activity by inducing DNA interstrand cross-links. Semustine, a chloroethyl
nitrosourea, is a 4-methyl derivative of lomustine. There exist some interesting reports dealing with DNA-binding prop-
erties of chloroethyl nitrosoureas; however, underlying mechanism of cytotoxicity caused by semustine has not been pre-
cisely and completely delineated. The present work focuses on understanding semustine–DNA interaction to comprehend
its anti-proliferative action at molecular level using various spectroscopic techniques. Attenuated total reﬂection–Fourier
transform infrared (ATR-FTIR) spectroscopy is used to determine the binding site of semustine on DNA. Conformational
transition in DNA after semustine complexation is investigated using circular dichroism (CD) spectroscopy. Stability of
semustine–DNA complexes is determined using absorption spectroscopy. Results of the present study demonstrate that
semustine performs major-groove-directed DNA alkylation at guanine residues in an incubation-time–drug-concentra-
tion-dependent manner. CD spectral outcomes suggest partial transition of DNA from native B-conformation to C-form.
Calculated binding constants (Ka) for semustine and lomustine interactions with DNA are 1.53 × 10
3 M−1 and
8.12 × 103 M−1, respectively. Moreover, molecular modeling simulation is performed to predict preferential binding
orientation of semustine with DNA that corroborates well with spectral outcomes. Results based on comparative study
of DNA-binding properties of semustine and lomustine, presented here, may establish a correlation between molecular
structure and cytotoxicity of chloroethyl nitrosoureas that may be instrumental in the designing and synthesis of new
nitrosourea therapeutics possessing better efﬁcacy and fewer side effects.
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Introduction
DNA, the genetic material of cell, is associated with
several vital biological processes such as replication, tran-
scription, and recombination. These auxiliary processes
and DNA itself can be targeted with small molecules or
ligands that may hold antitumor activity (Kennard, 1993;
Haq & Ladbury, 2000). Therefore, understanding physical
and chemical interaction properties of DNA and ligands
has become essential (Chaires, 1998). Interaction studies
have shown to be important to elucidate a correlation
between molecular structure of the drugs and their anti-
cancer activity (González-Ruiz et al., 2011; Mehrotra
et al., 2013). Results of such investigations may help in
the designing and synthesis of new drugs with fewer side
effects and more speciﬁcity (Nandy & Basak, 2010). One
of the major classes of cancer chemotherapeutics is alkyl-
ating agents, which are used in the treatment of various
types of cancer, viz multiple myeloma, sarcoma, and
lymphoma (Puyo, Montaudon, & Pourquier, 2013).
Semustine or [1-(2-chloroethyl)-3-(4-methylcyclohexyl)-
1-nitrosourea] (Figure 1(a)) is a member of chloroethyl
nitrosourea (CENU) family. It is a 4-methyl derivative of
lomustine or CCNU ([1-(2-chloroethyl)-3-cyclohexyl-1-
nitrosourea] (Figure 1(b)), also designated as methyl-
CCNU (Boice et al., 1983). It is used as an antineoplastic
alkylating agent to treat various types of malignancy
including Lewis lung carcinoma, leukemia, and metastatic
brain tumor. Semustine is also used to treat Hodgkin lym-
phoma, malignant melanoma, and lung carcinoma
(McCormick & Stanley McElhinney, 1990; Schabel,
1976). Semustine has lipophilic nature that enables its
distribution quickly across the tissues (Miyagami,
Tsubokawa, Tazoe, & Kagawa, 1990). This lipophilic
property allows it to cross the blood–brain barrier for the
chemotherapy of gliomas (Boice et al., 1983; Miyagami
et al., 1990). It has been shown that semustine interacts
with cellular DNA of highly dividing cells (McCormick
& Stanley McElhinney, 1990). CENUs are considered to
exert their anticancer activity by stimulating the formation
of DNA interstrand cross-links (ICLs) (Bai, Zhao, &
Zhong, 2010). Zhao and his colleagues have demonstrated
the comparative investigation among different CENUs
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(nimustine, carmustine, lomustine, and fotemustine),
regarding their ICLs activity with respect to their stability
in aqueous solution. They have also established a correla-
tion between ICLs activity of CENUs with their reported
anticancer efﬁciency (Zhao, Li, Xu, & Zhong, 2014;
Zhao, Ren, Bai, Zhang, & Zhong, 2011). Hayes et al.
studied a correlation between the exposure time of
CENUs to DNA and level of ICLs formed, using agarose
gel electrophoresis. Their results demonstrated that
increasing the exposure time led to an increase in the
quantity of ICLs formed (Hayes, Bartley, Parsons,
Eaglesham, & Prakash, 1997). Baoqing and his group
quantiﬁed dG-dC cross-links in oligonucleotide duplexes
induced by CENUs using HPLC/ESI-MS/MS method
(Bai, Zhao, & Zhong, 2011). There exist several reports,
which present the result of various investigations con-
ducted on the binding mechanism of CENUs with DNA
(Gombar, Tong, & Ludlum, 1980; Naghipur, Ikonomou,
Kebarle, & Lown, 1990; Schallreuter, Gleason, & Wood,
1990; Zhao, Zhong, & Zhen, 2007). Nevertheless,
detailed structural aspects, on the direct interaction of
semustine with DNA, are still obscure. Therefore, it is of
great importance to elucidate the peculiarities of semus-
tine–DNA complexation.
It has been reported that the binding site and binding
afﬁnity of a drug with its target are mainly governed by var-
ious non-covalent interactions (Snyder, Holt, Maguire, &
Trent, 2013). In view of this, we have performed molecular
modeling of semustine with DNA to predict its preferential
orientation and binding properties (Huang & Zou, 2010;
Morris et al., 1998b, 2009). Moreover, in the last few years,
spectroscopic techniques such as infrared (IR) and circular
dichroism (CD) have shown the potential to characterize
the nature of various biomolecules and their complexes,
particularly for their molecular structural information
(Agarwal, Jangir, & Mehrotra, 2013; Jangir, Kundu, &
Mehrotra, 2013; Tyagi, Charak, & Mehrotra, 2012).
Precisely, attenuated total reﬂection–Fourier transform
infrared (ATR-FTIR) spectroscopy has shown remarkable
potential in deciphering the binding characteristics of
various drug–DNA complexes (Jangir, Charak, Mehrotra, &
Kundu, 2011; Agarwal, Jangir, Singh, & Mehrotra, 2014).
Most importantly, ATR-FTIR spectroscopy enables the
environment modulation of the biomolecule so that
structural and conformational transition can be studied as a
function of temperature and pH to mimic the physiological
conditions (Braun et al., 2003). In addition, CD spectros-
copy reveals the details on the degree of conformational
alteration in DNA after its complexation with drug (Kypr,
Kejnovská, Renčiuk, & Vorlíčková, 2009). Binding mode
and stability of drug–DNA complexes can be assessed
using UV–visible spectroscopic technique (Braun et al.,
2003). Hence, with the present work, the competency of
ATR-FTIR, CD, and UV–visible spectroscopy is used to
evaluate various binding parameters of semustine–DNA
complex.
We report a comparative study on the DNA-binding
properties of semustine (methyl-CCNU) and lomustine
(CCNU) with respect to their interaction mode, preferen-
tial binding site and stability of their adduct with DNA.
Semustine and lomustine differ in their molecular struc-
ture by only one methyl group, nevertheless show differ-
ent cellular activity related to their initial binding site on
target molecule. As both of these CENUs are anti-
chemotherapeutic agents and used in the treatment of
various tumors, detailed comparative study on their pref-
erential interaction site and subsequent intracellular
action requires attention. Such relative assessment gives
a glimpse of structure–function relationship of the drug.
Further, these results may provide an input for rational
drug designing of new chloroethyl nitrosourea deriva-
tives with anti-cancer potential.
Materials and methods
Materials
Semustine (M.W. –247.7) and highly polymerized type I
calf thymus DNA (sodium content 6%) are procured
from Sigma Aldrich chemicals, USA. To estimate DNA
purity, the absorbance ratio of DNA at 260 nm (A260)
and 280 nm (A280) is calculated. The ratio of (A260)/
(A280) is found to be 1.83, which suggests sufﬁcient pur-
ity of DNA (Glasel, 1995). Deionized water (resistance
18.2 MΩ) from the Scholar-UV Nex UP 1000 system is
used for the preparation of buffer and semustine drug
solutions. Other chemicals and reagents utilized in this
investigation are of analytical grade.
Stock solutions preparation
DNA stock solution is prepared in tris-HCl buffer
(10 mM, pH 7.4) and placed at 8 °C for about 24 h. This
solution is stirred at regular time intervals to ensure the
homogeneity of DNA solution. Using molar extinction
coefﬁcient of 6600 cm−1 M−1, ﬁnal concentration of
Figure 1. Chemical structure of (a) semustine and (b) lomus-
tine. Red dotted circle contrasts the presence of methyl group
in semustine.
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DNA stock solution is measured spectrophotometrically
(Vijayalakshmi, Kanthimathi, Subramanian, & Nair,
2000) and is found to be 42 mM (due to phosphate
group molarity).
In silico study
The 3D structure of DNA dodecamer d(CGCGAA-
TTCGCG)2–benzimidazole complex is taken from RCSB
Protein Data Bank in PDB format (PDB ID: 453d)
(Neidle et al., 1999). Benzimidazole is unhooked from
the DNA–benzimidazole complex (453d) using UCSF
Chimera (Huang, Couch, Pettersen, & Ferrin, 1996). The
3D ﬁles of semustine (ID: 3831006) and lomustine (ID:
3874951) are obtained from Zinc database (Irwin,
Sterling, Mysinger, Bolstad, & Coleman, 2012) in mol2
format, which are then converted to PDB format using
off-line version of Open Babel 3.2.9 (O’Boyle et al.,
2011). AutoDock (version 4.2) is used for molecular
docking simulations (Morris et al., 2009). The Lamarck-
ian genetic algorithm (LGA) is adopted to perform the
molecular docking studies (Morris et al., 1998). B-DNA
(453d) is used as a rigid input receptor molecule for
docking, whereas semustine and lomustine are used as
ﬂexible ligands and number of active torsions are set to
4 (Goodsell, Morris, & Olson, 1996). AutoDockTools
version 1.5.6 (ADT) is used to prepare the receptor and
the ligand coordinate ﬁles in PDBQT format, as required
by AutoGrid and AutoDock for further simulations
(Sanner, 1999). Grid maps are computed using AutoGrid
considering grid box of dimension 62 × 62 × 20 with
.375 Å spacing. The grid center coordinates for semus-
tine and lomustine are set to 15.111, 20.786, and 13.837
and 15.111, 20.786, and 19.05, respectively. The docking
parameters used for modeling are listed in Table 1. A
ranked cluster analysis employing ADT is performed on
docking results for conformational analysis. All the 100
docked conformations are analyzed, and structurally sim-
ilar conformations are grouped into clusters, ranked in
the order of increasing energy using RMSD tolerance of
2.0 Å (Sanner, 1999). The lowest-energy docked con-
former is considered to be the best result and is used to
further analyze the molecular interactions of semustine
and lomustine with DNA (Morris et al., 1998; Huey &
Morris, 2008).
FTIR spectroscopy
For the FTIR spectroscopic investigation of free calf thy-
mus DNA and semustine–DNA complexes, Varian-660-IR
spectrophotometer is used. This instrument is equipped
with deuterated triglycine sulfate (DTGS) detector and KBr
beam splitter. To remove water vapors from sample cham-
ber, dry nitrogen gas is purged continuously. Miracle®
(PIKE) ZnSe-micro horizontal attenuated total internal
reﬂection (HATR) assembly is used for the sampling in
ATR mode. During experiments, ambient humidity of 46%
RH is maintained. For the spectral measurements of semus-
tine–DNA complexes, drug solutions of three different con-
centrations (.525, 1.05, and 4.2 mM) are prepared.
Thereafter, these drug solutions are added in a dropwise
manner to DNA solution (42 mM) to achieve 1/80, 1/40,
and 1/10 M ratios (r) of semustine–DNA complexes.
Continuous vortexing for 15 min followed by incubation at
room temperature for different periods (2, 4, 6, 8, and 24 h)
is performed to ensure the complete complexation of
semustine with DNA. Two-hundred and ﬁfty-six interfero-
grams are collected in the spectral range of 2400–700 cm−1
with a resolution of 2 cm−1. Before each spectral measure-
ment, background atmospheric spectrum is collected.
Multiple baseline corrections and normalization for DNA
band at 968 cm−1 are employed. To perform water
subtraction, a spectrum of tris buffer (10 mM) is recorded
and then subtracted from the spectra of free DNA and
semustine–DNA complexes. An acceptable water subtrac-
tion is regarded to be achieved, when the intensity of water
combination band at ~2200 cm−1 becomes zero in the
spectra of free DNA and drug–DNA complexes (Alex &
Dupuis, 1989).
CD spectroscopy
CD spectra are recorded on Applied Photophysics
(Chirascan) spectrophotometer. Spectral measurements are
taken using quartz cuvette having a pathlength of 1 mm in
the far UV range (200–320 nm). All the spectra are col-
lected at room temperature subsequent to varying degree
of incubation time (2, 4, 6, 8, 12, and 24 h) of semustine
with calf thymus DNA. Six scans are recorded with a
scanning speed of 1 nm/s and then averaged for each sam-
ple. Spectrum of buffer is subtracted from the spectra of
free DNA and semustine–DNA complexes to accomplish
buffer subtraction. For CD spectral measurements, semus-
tine solution of varying concentration (in the range of
.0625–.5 mM) are prepared and added into DNA solution
of constant concentration (5 mM) and thus, drug/DNA
molar ratios (r) become 1/80, 1/40, and 1/10.
Table 1. Molecular docking parameters.
Docking parameters Value
Number of individuals in population 150
Maximum number of energy evaluations 2,500,000
Maximum number of generations 27,000
Number of top individuals to survive to next
generation
1
Rate of cross over .8
Rate of gene mutation .02
Number of hybrid GA-LS or LGA runs 100
Studies of Semustine Binding with DNA 1655
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UV–visible spectroscopy
The absorption spectra of free DNA and its complexes
with CENUs (semustine and lomustine) are recorded on
Perkin-Elmer Lambda-35 spectrophotometer. For UV–
visible studies, .2 mM DNA solution is used with vary-
ing concentration of CENUs ranging from 2 × 10−1 to
2 × 10−2 mM. Quartz cuvette with a pathlength of 1 cm
is used for the measurements. Binding constants (Ka) for
the formation of CENUs–DNA complexes are calculated
assuming that only one type of interaction occurs
between DNA (D) and drug (S) in aqueous solution
resulting in the formation of one type of complex (DS)
(Connors, 1991). It is also presumed that DNA and
ligand follow Lambert–Beer’s law for the absorbance of
light. The absorbance of DNA solution (A0) at its total
concentration (Dt) with a path length (l) of 1 cm is:
A0 ¼ eDlDt (1)
where εD is the molar absorptivity of free DNA.
The absorbance of solution (AS) comprising of total
concentration of DNA (Dt) along with total concentration
of drug (St) is:
AS ! eDl D½  þ eSl S½  þ eDSl DS½  (2)
where
[D] is the concentration of uncomplexed DNA.
[S] is the concentration of uncomplexed drug.
[DS] is the concentration of drug–DNA complex.
εs is the molar absorptivity of drug.
εDS is the molar absorptivity of drug–DNA complex.
After combining with the mass balance of DNA and
drug, the absorbance equation can be written as:
AS ! eDl Dt þ eSl St þ D eDS l DS½  (3)
DeDS ! eDS  eD  eS
The absorbance of solution (A) measured against the
total concentration of drug as reference is
A ! eD l Dt þ DeDS l DS½  (4)
The stability constant (KDS) for the formation of complex
(DS) can be given as
KDS ! DS½ =½D½S (5)
Combining Equations (4) and (5)
DA ! KDS DeDSl½D½S (6)
DA ¼ A A0
From the mass balance equation Dt = [D] + [DS], we get
[D] = Dt/ (1 + KDS[S]), that gives following equation:
DA
l
! DtKDS DeDS ½S
1þ KDS ½S (7)
There is a hyperbolic relation between the free drug mol-
ecule concentration and its interaction with DNA. Linear
transformation of Equation (6) is done by taking the reci-
procal of both side of Equation (7) that can be presented
as:
l
DA
! 1
DtKDS DeDS ½S þ
1
DtDeDS
(8)
The double-reciprocal plot of 1/ΔA vs. 1/[S] is linear,
and the binding constant (K) can be calculated by esti-
mating the ratio of the intercept to the slope.
Results and discussion
Molecular docking analysis of semustine–DNA
complex
Figure 2(a) and (b) illustrate the docked model of
semustine with DNA. In the semustine–DNA docking
simulation of 100 runs, the majority of the binding con-
formers (66 poses) are obtained in the DNA major
groove, in contrast to 34 conformers in the DNA minor
groove. In addition, the most populated cluster, with 33
docked conformations; also belong to the major groove.
These, all together, can predict the major-groove-directed
binding of semustine (Figure 2(a)). To further analyze the
molecular level properties of semustine–DNA complexa-
tion (using ADT), the lowest-energy docked conformer in
major groove is selected, shown in Figure 2(b). Docking
study reveals that semustine interacts with DNA through
thymine, guanine, and cytosine nitrogenous bases.
Moreover, the docked model (Figure 2(b)) depicts the
formation of two hydrogen bonds, ﬁrst is between the
2nd oxygen atom of semustine (acceptor residue) and
H41 of 21st cytosine (donor residue) having 1.803 Å dis-
tance whereas 1st oxygen atom of ligand (acceptor) is
forming second hydrogen bond with cytosine (H41) at
3rd position (donor residue) with 2.045 Å distance.
Besides this, van der Waals interactions, in the semus-
tine–DNA docked model, are analyzed using ADT and
presented as spheres in the form of thin wireframes on
those pairs of atoms that are closer than the sum of their
van der Waals radii (Figure 2(b)). This establishes the
contribution of hydrogen bonds (ΔGhbond) and van der
Waals forces (ΔGvdw) in the overall binding free energy
of semustine with DNA (Table 2). The predicted binding
free energy for semustine–DNA complexation, that is, –
4.4 kcal/mol is in good agreement to that of the
experimental value (–4.35 kcal/mol) estimated from
UV–visible spectral outcome (Morris et al., 1998).
Furthermore, in AutoDock, the structure-based scoring
1656 S. Agarwal et al.
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method employs empirical free energy functions for the
prediction of interaction between ligands and their
macromolecular targets. However, the free energy of
binding (ΔGbind) is modeled in terms of dispersion and
repulsion (ΔGvdw), hydrogen bond (ΔGhbond), desolvation
(ΔGdesolv), electrostatic (ΔGelec), torsional free energy
Figure 2. (a) The docked model of semustine with DNA illustrating the major-groove-directed binding of ligand. (b) The lowest-
energy docked conformer of semustine–DNA complex (in major groove) revealing the interaction of semustine with DNA through
thymine, guanine, and cytosine nitrogenous bases. Moreover, the docked model depicts the formation of two hydrogen bonds between
the oxygen atom at 2nd position of semustine (acceptor residue) and H41 of cytosine at 21st position (donor residue) having distance
1.803 Å, while oxygen atom at 1st position of ligand (acceptor residue) is interacting with cytosine (H41) at 3rd position (donor resi-
due) with distance 2.045 Å. Besides this, van der Waals interactions are analyzed using ADT and presented here as spheres in the
form of thin wireframes on those pairs of atoms that are closer than the sum of their van der Waals radii. (c) Docked conformer of
lomustine–DNA complex exhibiting DNA minor-groove-oriented binding of ligand. (d) The best docked structure of lomustine and
DNA based on minimum binding energy. It shows the direct interaction of lomustine with DNA nitrogenous bases, guanine, and cyto-
sine. This conformer exhibited two hydrogen bonds; hydrogen atom at 12th position of lomustine (donor residue) forms hydrogen
bond with O4′ of deoxyribose sugar moiety (acceptor residue) linked to guanine at 22nd position having distance 2.09 Å, whereas
oxygen atom at 2nd position of ligand (acceptor residue) is interacting with guanine (H3) at 22nd position (donor residue) with
distance 2.037 Å.
Table 2. Predicted binding free energy values (kcal/mol) for lowest-energy docked conformer of CENUs with dodecamer d
(CGCGAATTCGCG)2.
Drug
Predicted
Binding Free
Energy
ΔGbind
a
Final Inter-
molecular
Energy
ΔGinter
b
vdW + hBond +
desolvation Energy*
ΔGvdw + hbond +
desolv
Electro-
static
Energy
ΔGelec
Total
Internal
Energy
ΔGtotal
Torsional
Free
Energy
ΔGtor
Unbound
System’s
Energy
ΔGunb
Experimentally
Calculated
Energy ΔGobs
Semustine −4.40 −5.59 −5.57 −.02 +.05 +1.19 +.05 −4.35
Lomustine −6.36 −7.55 −7.57 +.02 +.16 +1.19 +.16 −5.33
aΔGbind = ΔGinter
b + ΔGtotal+ΔGtor – ΔGunb.
bΔGinter = ΔGvdw + hbond + desolv + ΔGelec.
*ΔGvdw + hbond + desolv is the sum of van der Waals energy (ΔGvdw), hydrogen bond energy (ΔGhbond), and desolvation energy (ΔGdesolv).
Studies of Semustine Binding with DNA 1657
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(ΔGtor), ﬁnal total internal energy (ΔGtotal), and unbound
system’s energy (ΔGunb) (Morris et al., 1998). This may
be written as:
DGbind ¼ DGvdw þ DGhbond þ DGdesolv þ DGelec þ DGtor
þ DGtotal  DGunb
Further, it has been reported that favorable binding
between receptor and ligand is majorly driven by the
electrostatic, hydrogen bond, hydrophobic, and van der
Waals interactions (Strange, 1996). Referring to Table 2,
the degree of electrostatic energy (ΔGelec), that is,
–.02 kcal/mol is very less, which proposes negligible
contribution of electrostatic interactions in case of
semustine–DNA complexation. Besides this, desolvation
free energy (ΔGdesolv), which models desolvation upon
ligand binding, is used as a measure of hydrophobic
forces (Aksel, Majumdar, & Barrick, 2011; Morris et al.,
1998; Rueda, Banerjee, Aziz, & Raza, 2010). Further-
more, it is difﬁcult to differentiate the individual contri-
bution of hydrophobic and van der Waals forces in
ligand–receptor binding, since van der Waals forces may
also add interactions between nonpolar (aromatic and ali-
phatic) species (Strange, 1996). Here, AutoDock
simulation results provide the sum of van der Waals,
hydrogen bond, and desolvation energies (ΔGvdw+
ΔGhbond + ΔGdesolv) as a single value, which is predicted
as –5.57 kcal/mol (Table 2). The docking analysis, pre-
sented here, illustrates van der Waals interactions, hydro-
gen bonds, and hydrophobic forces rather than
electrostatic forces that are governing semustine–DNA
complexation.
FTIR spectroscopic analysis
DNA nitrogenous base binding
Spectroscopic investigation of semustine–DNA com-
plexes is performed to validate docking results. FTIR
spectrum of free semustine is collected (Figure 4) and
subtracted from drug–DNA complex spectrum. This is
done to ensure that observed spectral variations in DNA
are due to semustine binding. Besides this, IR spectral
measurements for all the molar ratios of semustine–DNA
complexes are recorded with respect to different incuba-
tion time ranging from 2 to 24 h to get more insights of
semustine anti-cancer action mechanism. Figures 5 and 6
show infrared spectral characteristics observed in the
spectrum of free calf thymus DNA and semustine–DNA
complexes. Stretching vibrations due to nitrogenous
bases (C=O, C=N), deoxyribose pentose sugar, and phos-
phate groups (PO2 asymmetric and symmetric) of DNA
occur in the spectral range of 1800–700 cm−1. In-plane
stretching vibrations of guanine (G) due to C6=O6 and
C6=N1 bonds in DNA major groove lead to emergence
of infrared bands at 1713 and 1574 cm−1, respectively.
The band at 1654 cm−1 is assigned to thymine (T)
stretching vibrations, which correspond to C4=O4 bonds.
The bands at 1492 and 1609 cm−1 are ascribed to the
stretching vibrations of cytosine (C=C) and adenine
(C=N), respectively. In addition, in-plane stretching
vibrations owed to C4=NH2 bonds of cytosine in DNA
major groove induces the appearance of infrared band at
1297 cm−1. The infrared band at 1526 cm−1 is attributed
to in-plane stretching vibrations of guanine and cytosine
base pair (Banyay, Sarkar, & Gräslund, 2003).
After the addition of semustine into DNA, IR spectral
features associated with nitrogenous bases exhibit a varia-
tion pattern in an incubation-time–drug-concentration-
dependent manner. The infrared band at 1654 cm−1,
which is accredited to thymine (C4=O4 bonds in DNA
major groove), demonstrates major spectral upshift of
7 cm−1 at highest semustine concentration (R-1/10) after
2 h of drug–DNA incubation (Figure 5(a)). This spectral
shift is also accompanied with the deviation in intensity
as evident by the positive band at 1652 cm−1 in the differ-
ence spectra of semustine–DNA complexes [(DNA solu-
tion + semustine solution) – DNA solution] (Figure 5(b)).
Furthermore, it has been noticed that as the incubation
time increases, spectral variations for thymine in terms of
IR band shift and intensity become reduced (manifested
by the IR band at 1654 cm−1 in Figure 6(a) and (c)).
Besides this, a minor downshift of 1 cm−1 is observed for
guanine band at 1713 cm−1 in the spectra of semustine–
DNA complexes following 2 h of incubation (Figure 5(a)).
With the increase in incubation time, spectral variations
(band shift and intensity) for guanine enhance as apparent
by IR band at 1708 cm−1 depicting downshift of 5 cm−1
(Figure 6(a)) and by the sharp negative band at
1719 cm−1 signifying decrease in intensity of guanine
stretching vibrations (Figure 6(b)). Moreover, ensuing to
8 h of semustine–DNA incubation, IR spectral alterations
for guanine becomes stable as obvious by the
1708 cm−1 IR band (Figure 6(c)) and 1722 cm−1 negative
band (Figure 6(d)) in drug–DNA spectra following 24 h
of incubation. In addition, cytosine exerts spectral varia-
tions similar to guanine. Till 4 h of semustine–DNA incu-
bation, IR band 1492 cm−1, ascribed to cytosine,
demonstrates negligible shift and intensity variation as
manifested by the presence of band at 1492 cm−1
(Figure 5(a)) and 1491 cm−1 (Figure 5(c)). Consequent to
8 h of incubation (Figure 6(a)), highest spectral shift
(4 cm−1 downshift) and intensity change (positive band at
1484 cm−1) is noticed for cytosine, which further
becomes stable following 24 h of semustine–DNA incu-
bation (Figure 6(c)). Along with the spectral variations
(shifts and intensity change), percent effect of semustine
binding with respect to different molar ratios and incuba-
tion periods on IR bands representative of reactive sites
of DNA nitrogenous bases is depicted in Figure 7.
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Spectral changes observed in terms of shifts and
intensity deviations of base vibrations of DNA helix
suggest the direct binding of semustine to heterocyclic
base pair of DNA with major emphasis on thymine
(band at 1654 cm−1), guanine (band at 1713 cm−1), and
cytosine (band at 1492 cm−1) (Ahmad, Arakawa, &
Tajmir-Riahi, 2003). Adenine band at 1609 cm−1 neither
underwent a shift in its position nor experienced any
change in its infrared absorption intensity, signifying that
semustine–DNA interaction is independent of adenine
participation. Based on the infrared spectral analysis in
conjunction with docking study, it can be inferred that
semustine does not directly bind to guanine bases rather
it initially interacts with thymine (C4=O4) residues in
order to make proper contact with DNA duplex and sub-
sequently performs its antitumor action. This preliminary
binding may be carried out by hydrophobic forces
exerted by the methyl group of semustine (Banerjee
et al., 2014). In addition, C4=O4 group of thymine is
located within DNA major groove; hence, it can be sug-
gested that semustine performs major-groove-oriented
action (Agarwal, Jangir, Mehrotra, Lohani, & Rajeswari,
2014). Preliminary binding of semustine with DNA may
be followed by nucleophilic attack of 2-chloroethyl moi-
ety of the drug on O6 position of guanine, resulting in
the formation of O6-chloroethyl guanine adducts. Subse-
quently, O6-chloroethyl guanine may undergo
intramolecular rearrangement to stimulate the formation
of N1-O6 ethano-guanine adducts (Gombar et al., 1980;
Naghipur et al., 1990; Tong, Kirk, & Ludlum, 1983).
This adduct formation can be traced by the spectral vari-
ation at 1574 cm−1 infrared band, ascribed to C6=N1
stretching vibrations of guanine residues in DNA major
groove (Figure 6(a) and (c)) (Banyay et al., 2003). Sub-
sequently, N1-O6 ethano-guanine adduct may react with
N3 of cytosine in the complementary strand of DNA to
produce dG-dC interstrand cross-links (1-(3-cytosinyl)-2-
(1-guanosinyl)-ethane) (Gombar et al., 1980; Naghipur
et al., 1990; Tong et al., 1983). This is evident from the
spectral alterations of IR bands at 1526 and 1297 cm−1,
which are accredited to in-plane stretching vibrations of
guanine and cytosine base pair and C4-NH2 group of
cytosine in DNA major groove, respectively (Figure 6(a)
and (c)) (Banyay et al., 2003). In addition, it has been
observed that spectral variations for the IR bands of
cytosine and guanine are increased progressively with
the incubation time, tending toward a steady state at
about 8 h. Such spectral alteration can be the aspect of
critical time, which is required by the ligand or drug
molecule to exert its action mechanism entirely. There-
fore, it can be proposed that anti-cancer action of semus-
tine takes place in two phases: induction phase and
execution phase. Induction phase is characterized by the
preliminary binding of drug with thymine (C4=O4
group) in DNA major groove leading toward the
buffering stage for the formation of O6-chloroethyl guan-
ine adducts, as apparent by the minor shift and intensity
variation for IR bands at 1713 cm−1 (guanine C6=O6),
1492 cm−1 (cytosine C=C), and 1297 cm−1 (cytosine
C4-NH2) (Figure 5). Induction phase is followed by the
execution phase, which is designated by an augmentation
in the dG-dC interstrand cross-links formation (Figure 6).
This is further affected by the semustine concentration,
as the highest drug concentration (R-1/10) not only
accelerates the rise of dG-dC interstrand cross-links,
rather also favors the shortening of induction period. The
dG-dC DNA interstrand cross-links formation, induced
by semustine, ﬁnally attained a maximum steady state
after 8 h (Tang, Zhao, & Zhong, 2008). Additionally, it
can be presumed that induction phase is more signiﬁcant
as it forms the grounds for the subsequent anti-cancer
action of semustine (i.e., DNA cross-linking). Moreover,
cross-links generated by semustine induce the partial
denaturation of DNA duplex, which can arrest the nor-
mal functions of DNA such as replication, transcription,
and recombination in the cells and may cause cell death.
This is in accordance with the previous reported investi-
gations that “cross-links induced by DNA alkylating
agent can locally destabilize the double helix followed
by the opening of duplex” (Lenglet & David-Cordonnier,
2010; McCann, Lo, & Webster, 1971). This investigation
concludes that semustine induces major-groove-directed
DNA alkylation and produces dG-dC interstrand cross-
links of DNA (however, it goes through two phases). In
addition, the degree of cross-linking augments with the
incubation time in a drug-concentration-reliant manner,
which at the end achieves a stable form (Tang et al.,
2008).
DNA phosphate–sugar backbone binding
In the FTIR spectrum of free DNA (Figures 5 and 6), the
bands at 1083 and 1219 cm−1 are due to symmetric and
asymmetric stretching vibrations of phosphate group,
respectively (Banyay et al., 2003). The IR band at
1219 cm−1 consistently shows no appreciable shift except
1–2 cm−1 upon semustine complexation with DNA at all
through the range of incubation time from 2 to 24 h.
Besides this, the band at 1083 cm−1 (accredited to phos-
phate symmetric stretching vibrations) manifests similar
spectral variations as exhibited by 1219 cm−1 band (upper
panels of Figures 5 and 6). In the FTIR difference spectra,
slight infrared hyperchroism is observed at 1206 and
1080 cm−1 (Figure 5(d)) that signiﬁes minor alteration in
intensity of phosphate stretching vibrations in DNA after
its interaction with semustine. Similarly, in the IR spec-
trum of free DNA, infrared bands at 968 and 1052 cm−1
refer to C–C and C=O deoxyribose sugar stretching vibra-
tions, respectively (Banyay et al., 2003). Utmost
1–2 cm−1 spectral shift is noticed for the bands at
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1052 cm−1 and at 968 cm−1 after drug–DNA complex
formation (Figure 6(a)). Moreover, both of these bands
(968 and 1052 cm−1) show an enhancement in intensity as
manifested by positive spectral features at 962 and
1046 cm−1 in the difference spectra (Figure 5(d)). Infrared
bands at 1372 and 780 cm−1 are assigned to C2′/C3′
endo–anti- and main N-type C3′ endo–anti-sugar confor-
mations, respectively. In addition, the band at 725 cm−1 is
ascribed to out-of-plane stretching vibrations of C3′ endo/
anti-sugar conformation (Banyay et al., 2003). These
bands show minor shift of 1 cm−1 when semustine–DNA
interaction takes place. This minor shift is accompanied
with slight variation in intensity in sugar stretching vibra-
tions as indicated by positive bands at 1385, 780, and
724 cm−1 in the difference spectra of semustine–DNA
complexes (Figure 5(d)). These spectral outcomes indicate
toward minor external binding of semustine with DNA
duplex through sugar–phosphate backbone (Agarwal,
Jangir, Singh et al., 2014; Jangir et al., 2011).
DNA conformation
Infrared band at 837 cm−1, attributed to C2 endo–anti-/S-
type-sugar pucker–phosphodiester stretching vibrations,
is considered as a primary marker band for B-form of
DNA (Figure 6(a)). In addition, the infrared bands at
893 cm−1 (due to pentose ring stretching vibrations) and
1219 cm−1 (due to PO2 antisymmetric stretching vibra-
tions) also signify DNA conformation in B-form. Besides
this, the IR bands at 1422 and 936 cm−1 are ascribed to
C2′ endo deoxyribose sugar conformation in B-form
helices. Moreover, one of the main DNA conformational
component, that is, β-C/N-glycosidic linkage is denoted
by the emergence of band at 1456 cm−1 (Banyay et al.,
2003). Furthermore, the shoulder pattern, generated by
the IR bands at 1083 and 1052 cm−1, is the key indicator
for proper DNA hydration value (Jangir et al., 2013;
Loprete & Hartman, 1993; Pohle et al., 2000). After the
formation of semustine–DNA complex, minor shift of
2–3 cm−1 is observed at these conformational infrared
bands (1219, 893, 837, 1422, and 1457 cm−1) (Figures 5
and 6). This minor shift is accompanied with the skewed
manifestation of shoulder as the deeper minimum is
observed at 1070 cm−1, which signiﬁes lower level of
DNA hydration ensuing its resemblance to the spectrum
of C-conformation (Figure 6(a)) (Loprete & Hartman,
1993; Pohle et al., 2000). However, these spectral altera-
tions are observed in conjunction with the presence of
B-conformation marker bands. Therefore, it can be con-
cluded that semustine complexation with DNA duplex
induces slight dehydration leading to the development of
some C-form features, which subsequently forms a tran-
sitional state in double helix (B–C-conformation)
(Agarwal et al., 2014).
CD spectroscopic analysis
Spectral changes in CD for calf thymus DNA in the
absence and presence of increasing amount of semustine
are recorded as a function of time to get detailed insights
in the alkylation mechanism and subsequently induced
conformational transition in DNA molecule (Figure 8).
Helix with right-handedness and β-C/N-glycosidic link-
ages with asymmetrical arrangement of B-form of DNA
give rise to a characteristic CD spectrum, which consists
of positive as well as negative elliptical components: posi-
tive bands (at 277 nm and 223 nm) and negative bands (at
248 nm and 214 nm). Positive band at 277 nm emerges
due to stacking interaction between nitrogenous bases of
DNA, while second positive band at 223 nm signiﬁes
hydrogen bonds occurring between bases of complemen-
tary strands. Negative band at 248 nm indicates
right-handedness of B-DNA double helix, whereas other
negative band at 214 nm arises due to the β-C/N-
glycosidic bond occurring between nitrogenous base
and deoxyribose sugar (Johnson, 1994; Miyahara,
Nakatsuji, & Sugiyama, 2012). Variation in these typical
band positions and in ellipticity indicates corresponding
conformational transitions in DNA double helix owing to
its interaction with a ligand or drug (Kypr et al., 2009).
CD spectra, collected after 2 h of incubation of
semustine and DNA, exhibit a spectacular alterations at
all the molar ratios. The band accredited to base stacking
interaction (at 277 nm) manifests enhancement in molar
ellipticity in conjunction with 4-nm hypsochromic shift
(273 nm) in a drug-concentration-dependent manner as
maximum ellipticity is observed at higher semustine con-
centrations (R-1/10 and 1/40). Besides this, the band at
248 nm (assigned to DNA helicity) is intensiﬁed along
with a slight blue shift of 1 nm upon the interaction of
semustine with DNA. Nevertheless, the maximum mag-
nitude of negative ellipticitical component (247 nm) is
observed at the highest semustine–DNA molar ratio
(R-1/10). The other dichroic components at 223 nm
(assigned to hydrogen bonding between bases of comple-
mentary strands) and 214 nm (signifying β-C/N-glyco-
sidic bond) demonstrate minor increase in molar
ellipticity at all the molar ratios along with no spectral
shift. These dichroic spectral changes may designate ini-
tial alterations in DNA duplex due to its interaction with
semustine and reﬂect the formation of a reversible drug–
DNA complex, in which semustine attempts to make sta-
ble contact with nucleic acid (Agarwal et al., 2014).
Further, it can be suggested that this preliminary com-
plexation is driven by non-covalent interactions of
semustine with thymine (C4=O4) in DNA major groove
as also evident by IR spectral shift and intensity varia-
tion at 1654 cm−1 band during the beginning hours of
incubation (Figure 5(a)). Following the 4 h of incuba-
tion, CD spectra of semustine–DNA complexes reveal
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dichroic aspects similar to that of 2 h except that maxi-
mum positive ellipticity (at 277 nm, green line) is mani-
fested by the lowest drug concentration (R-1/80).
Moreover, the band at 248 nm, referred to B-DNA
duplex helicity, shows more pronounced spectral shift
(blue shift of 2 nm) and ellipticity change (45% intensiﬁ-
cation) at all the molar ratios. Therefore, it is concluded
that dichroic pattern exhibited by semustine–DNA com-
plexes is drug-concentration and incubation-time depen-
dent, since the trend pursued by lower molar ratio (R-1/
80) at 4 h of incubation has been previously followed by
the higher molar ratios (R-1/10 and 1/40) at 2 h of incu-
bation. CD spectral attributes, observed at 6 h of DNA
incubation with semustine, evolve into a variable-
cum-stable form and demonstrate single isodichroic
(isosbestic) point at 258 nm. These outcomes provide the
spectral evidence for the development of a reactive inter-
mediate in semustine–DNA reaction and system in equi-
librium consisting of bound and free drug molecules
(Brahms, Brahms, & Van Holde, 1976; Li, 2012). At 8 h
of incubation of semustine–DNA complexes, CD spectra
exhibited maximum changes in dichroic components
ellipticity and position. After the interaction of semustine
with DNA (at 8 h), the band at 277 nm (ascribed to base
stacking interaction) exhibits an augmentation in elliptic-
ity (93%) at all the molar ratios; nevertheless, this ellip-
ticity variation is accompanied with no spectral shift.
Besides this, the band at 248 nm (right-handed helicity
of B-DNA) exhibits intensiﬁcation (70%) along with
2-nm hypsochromic shift. Based on these spectral varia-
tions, it can be proposed that semustine complexation
with DNA induces mild distortion in base stacking and
slight deviation in local base-pair geometry of double
helix. Moreover, the molar ellipticity at 277 nm pos-
sesses a linear correlation with DNA winding angle and
propeller twist, as its augmentation (molar ellipticity at
277 nm) induces the reduction in DNA winding angle
(opening of DNA duplex locally) and enhancement in
DNA propeller twist (Chan, Kilkuskie, & Hanlon, 1979).
Subsequently, alteration in these native properties of
B-DNA (winding angle and propeller twist) causes small
change in number of base pairs per turn in DNA duplex
(Patil & Rhodes, 2000; Portugal & Subirana, 1985).
Therefore, altogether, these spectral alterations make a
prospect for the transition of native DNA conformation
from B-form (10.4 base pair/helical turn) to C-form (9.2
base pair/helical turn) (Bokma, Curtis, & Blok, 1987;
Portugal & Subirana, 1985; Zhang, Huang, Tang, Wang,
& Dong, 2002). However, this transition appears to be
limited up to few base pairs of DNA as for the complete
transformation from B- to C-form, ellipticity at 248 nm
must be in the exact ratio of two-third (66%) to that of
B-DNA band, while here, we observed 70% intensiﬁca-
tion (Bokma et al., 1987; Brahms, Pilet, Lan, & Hill,
1973; Portugal & Subirana, 1985). Thereby, there is a
possibility for the formation of a B–C-intermediate con-
formation of DNA duplex that possesses features of both
B- and C-form (as apparent from FTIR spectral results).
Besides this, hypsochromic shift and intensiﬁcation at
248 nm band is also associated with the reduction in
DNA hydration that runs along the inner edges of major
groove around phosphate group. Further, it has been
reported that guanine is hydrogen bonded to a water
molecule from C6=O6 group in DNA major groove with
single hydration on the free ring nitrogen atom N7-major
groove. In addition, thymine is hydrogen bonded to
a water molecule from C4=O4 group in major
groove (Berman & Schneider, 1999; Degtyareva,
Wallace, Bryant, Loo, & Petty, 2007; Woods, Lan,
McLaughlin, & Williams, 2003). Moreover, increase in
propeller twist or decrease in DNA winding angle (as
evident from spectral alteration at 277 nm band) is
accounted for DNA groove widening that facilitates the
appropriate positioning of ligands within groove pocket
(Agarwal et al., 2014). Therefore, it can be suggested
that semustine interacts with DNA via hydrophobic
forces and primarily binds with thymine residues
(C4=O4 group) within DNA major groove ensuing the
distortion of well-organized water network. Subse-
quently, it results in slight DNA dehydration, which
induces structural transition (establishment of B–C-
intermediate form) and reduction in free energy essential
for DNA twisting leading to DNA denaturation (Berman
& Schneider, 1999). This is supported by the fact that
“alkylating agents may destabilize the DNA duplex by
means of base ﬂipping, DNA bending, and/or double-
helical strand opening” (Lenglet & David-Cordonnier,
2010). Besides this, CD spectra of semustine–DNA com-
plexes illustrate isoelliptic behavior at 231 and 258 nm
(isosbestic points shown by red circles in Figure 8). This
can be ascribed to semustine induced two-state transition
in DNA molecule (Mayer & Drago, 1976; Kankia,
Barany, & Musier-Forsyth, 2005), as semustine exerts its
anti-cancer mechanism of action in two phase (formation
of O6-chloroethyl guanine adducts pursued by the devel-
opment of dG-dC DNA cross-links). Further, this is in
corroboration with the FTIR spectral outcomes that
signify an initial interaction of semustine with thymine
followed by the formation of dG-dC DNA cross-links. In
addition, other CD bands at 223 nm (accredited to
hydrogen bonds occurring between purine and pyrimi-
dine of complementary strands) and 214 nm (ascribed to
β-C/N-glycosidic bond) manifest slight enhancements in
their molar ellipticity accompanied with no spectral shift
after the interaction of semustine with DNA. This change
in molar ellipticity at 223 nm is ascribed to slight distur-
bance in hydrogen bonding, which may be a consequent
of dG-dC DNA cross-links formation. Furthermore, the
change in elliptical behavior of dichoric component at
214 nm can be outcome of the deviation in DNA
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propeller twist that may inﬂuence β-C/N-glycosidic bond
orientation (Agarwal et al., 2013, 2014). In addition, it
has been observed that CD spectral variations
accomplish a steady state after 8 h of incubation.
UV–visible spectroscopic analysis
Binding mode
The absorption spectra of free calf thymus DNA and its
complexes with varying concentrations of CENUs
(semustine and lomustine) are shown in Figure 9. The
absorption spectra of DNA manifested quite similar
behavior on addition of semustine and lomustine. When
CENUs interact with DNA, they cause hyperchromic
effect with increasing concentration of drugs in solution.
This hyperchromic effect can be assigned to the binding
of semustine and lomustine to DNA followed by base
alkylation (Tyagi, Jangir, Singh, & Mehrotra, 2010;
Tyagi et al., 2012). Alkylated base residues may generate
interstrand cross-links that result in localized distortion
and denaturation in double helix (as evident from FTIR
and CD spectral outcome). This localized deformation
may induce more exposure of bases to UV radiation,
which leads to an enhancement in the absorption of UV
radiation (Tyagi et al., 2010, 2012).
Binding strength of CENUs–DNA complexes
The binding constant (Ka) is calculated for the quantita-
tive measurement of binding of semustine and lomustine
with DNA. It is calculated by observing the changes in
optical density at 260 nm for free DNA (represented by
A0) and its complexes with CENUs (represented by A).
It includes the preparation of a series of drug–DNA
complex solutions in which the concentration of DNA is
held constant, while the drug concentration [C] is varied
from 2 × 10−1 to 2 × 10−2 mM. The double-reciprocal
plot of 1/ (A–A0) versus 1/ [C] is linear and the binding
constant (Ka) can be estimated from the ratio of intercept
to slope (intersect of Figure 9). The binding constants
(Ka) for the interaction of semustine and lomustine with
DNA are 1.53 × 103 M−1 and 8.12 × 103 M−1, respec-
tively, which indicate moderate type of CENU’s binding
with DNA duplex (Tyagi et al., 2012). Furthermore, it
has been observed that the stabilities of both drug’s com-
plexes with DNA exhibit a little difference (though in
the same range 103), which can be accredited to the
slight molecular structural change between the two
CENUs. Besides this, free energy for CENUs binding to
DNA can be calculated using the following relation:
DGobs ¼ RT lnKa
where ΔGobs is the observed binding free energy, R is
the gas constant (1.987 cal K−1 mol−1), T is the absolute
temperature (298.15 K), and Ka is the binding constant.
In the case of semustine, the value of Ka is 1.53 ×
103 M−1, thereby
Figure 3. The docked model of semustine–DNA and lomus-
tine–DNA, having duo CENUs in the superimposed position.
Figure 4. FTIR spectrum of semustine in the region of 1800 to 700 cm−1.
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DGobs ¼ ð1:987Þ  ð298:15Þ  lnð1:53 103Þ
¼ 4:35 kcal/mol
While for lomustine Ka is 8.12 × 10
3 M−1 and hence:
DGobs ¼ ð1:987Þ  ð298:15Þ  ln ð8:12 103Þ
¼ 5:33 kcal/mol
These calculated binding energies are consistent to that of
predicted by molecular docking simulations (Table 2) of
lomustine (–6.36 kcal/mol) and semustine (–4.4 kcal/mol)
(Morris et al., 1998).
Comparison of semustine–DNA and lomustine–DNA
adducts
Semustine and lomustine both interact with DNA via its
nitrogenous bases. Effect of lomustine is found to be
more pronounced than semustine as apparent from its
overall larger effect on guanine and cytosine bases in
terms of infrared spectral shifts and intensity variation
(Agarwal et al., 2014). The binding free energy values of
the docked semustine–DNA and lomustine–DNA com-
plexes (Table 2) provide another evidence for the stronger
DNA-binding afﬁnity of lomustine (–6.36 kcal/mol)
Figure 6. FTIR spectra of free calf thymus DNA and its complexes with chloroethyl nitrosourea derivative semustine in region of
1800 to 700 cm−1 at different molar ratios after (a) 8 h and (c) 24 h of incubation periods (upper section). Lower section demon-
strates parallel difference spectra of semustine–DNA complexes (b) at 8 h and (d) at 24 h.
Figure 7. Percentage effect of semustine binding on DNA nitrogenous bases guanine (C6=O6 at 1713 cm−1 and C6=N1 bonds at
1574 cm−1), cytosine (C=C at 1492 cm−1 and C4=NH2 bonds at 1297 cm−1), adenine (C=N at 1609 cm−1) and, thymine (C4=O4 at
1654 cm−1), estimated as a function of semustine concentration and incubation time.
1664 S. Agarwal et al.
D
ow
nl
oa
de
d 
by
 [N
ati
on
al 
Ph
ys
ica
l L
ab
or
ato
ry
 ] 
at 
02
:46
 21
 Se
pte
mb
er 
20
15
 
than that of semustine (–4.4 kcal/mol), as more negative
value of binding energy is an indication of more potent
binding of the ligand with its receptor (Zheng et al.,
2014). Besides this, infrared results suggest the interac-
tion of lomustine with guanine and cytosine bases of
DNA, which draw a parallel understanding with the
molecular docking outcomes (Figure 2(d)) (Agarwal
et al., 2014). However, semustine initially binds to
thymine residues as indicated by docked conformation
(Figure 2(b)) and spectral shift in combination with
intensity variation at 1654 cm−1 infrared band (Figure 5).
Both CENUs interact with DNA sugar–phosphate
backbone to some extent, which augments their binding
and may facilitates proper positioning of CENUs on
DNA for their subsequent cytotoxic action. Moreover, in
the lomustine–DNA molecular docking simulation of 100
runs, lomustine exhibited 65 conformers in DNA minor
groove and 35 conformers in major groove of DNA
(under same docking conditions as used for semustine).
This illustrates that lomustine plausibly binds in DNA
minor groove, whereas semustine preferentially binds in
DNA major groove (Figure 3). The lomustine–DNA
docked model exhibited two hydrogen bonds formed
between the lomustine and guanine (Figure 2(d)). The
hydrogen atom at 12th position of lomustine forms
hydrogen bond (donor) with O4′ of deoxyribose sugar
Figure 8. Circular dichroism spectra of free DNA and semustine–DNA complexes at different molar ratios 1/10 (red line), 1/40
(blue line), and 1/80 (green line) against various incubation periods. Here, red circles exemplify the existence of isosbestic point.
Figure 9. UV–visible spectra of free calf thymus DNA (.2 mM) in the absence and presence of semustine (a) and lomustine (b).
Intersect shows double-reciprocal plot of drug binding to DNA. A0 and A is the absorption of DNA at 260 nm in free and complexed
state, respectively. C is the analytical concentration of drug in solution.
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moiety linked to guanine at 22nd position (acceptor) with
distance of 2.09 Å, whereas oxygen atom at 2nd position
of ligand (acceptor) is interacting with guanine (H3) at
22nd position (donor) with 2.037 Å distance. CD spectral
proﬁle depicts the difference in the binding pattern of two
CENUs with respect to conformational transition
in DNA. Lomustine interaction with DNA induces
alterations in native B-conformation of DNA related to
local base-pair geometry and stimulates transition from
B- to A-form (Agarwal et al., 2014). However, upon
semustine–DNA complexation, DNA hydration value is
lowered and induces some C-form features followed by
the formation of a transitional B–C-conformation.
Although not much difference is observed in the binding
constants of both the CENUs–DNA complexes, overall
effect on the structure of DNA is found to be more for
lomustine between the two CENUs studied. These
outcomes may be helpful in addressing the issues
of structure-based activity of both CENUs and
investigations related to more potency of lomustine than
semustine in spite of little difference in their chemical
structure.
Conclusion
In the present work, we carried out molecular docking
and spectroscopic investigations on the binding proper-
ties of chloroethyl nitrosourea derivative semustine with
DNA duplex. FTIR spectral outcomes suggest primarily
binding of semustine with thymine followed by dG-dC
DNA cross-link formation, which further authenticate
molecular modeling prediction. Moreover, minor external
binding of semustine with phosphate–sugar backbone of
DNA is also indicated by FTIR spectral results. Binding
energy for semustine–DNA interaction is predicted to be
–4.4 kcal/mol, revealing dominance of van der Waals,
hydrogen bond, and hydrophobic forces over electro-
static interactions for semustine–DNA complexation. CD
spectroscopic data indicate the formation of an interme-
diary form of DNA during the transition from B- to C-
form locally after semustine–DNA complexation,
although overall DNA remains in native B-form. Fur-
thermore, DNA-binding mechanism of semustine is com-
pared with that of lomustine. This suggests that
lomustine has more prominent effect than semustine with
respect to their interaction with DNA double helix.
These ﬁndings may add further understanding about the
action mechanism of chloroethyl nitrosourea derivative
at molecular level.
Abbreviations
UV Ultraviolet
CENUs chloroethyl nitrosoureas
CD circular dichroism
CCNU [1-(2-chloroethyl)-3-cyclohexyl-1-
nitrosourea]
ICLs interstrand cross-links
RMSD root-mean-square deviation
PDB Protein Data Bank
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